SWOG clinical trial number

SWOG-8402

Evaluation of Esorubicin in Ovarian Cancer

Closed

Phase

Published

Abbreviated Title

Evaluation of Esorubicin in Ovarian Cancer

Activated

06/11/1984

Closed

12/15/1986

Publication Information Expand/Collapse

1992

A phase II evaluation of esorubicin in ovarian cancer. A Southwest Oncology Group study.

DS Alberts;NM Liddil;D Stock-Novack;RV O'Toole;TM Abbott;SE Salmon AJCO 15(2):146-149